Pharmacokinetics and Safety of Ferric Pyrophosphate Citrate Intravenous: Equivalence to Administration via Dialysate.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of clinical pharmacology"
DOI: 10.1002/jcph.1997
Abstract: Ferric pyrophosphate citrate (FPC) is indicated to maintain hemoglobin in chronic hemodialysis patients (CKD-5HD) by addition to the dialysate. An intravenous (IV) FPC presentation containing 6.75 mg iron in 4.5 mL was developed. The objective… read more here.
Keywords: fpc; equivalence; pyrophosphate citrate; post ... See more keywords
Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety
Sign Up to like & getrecommendations! Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2092373
Abstract: Abstract Anemia is a common complication in patients with hemodialysis-dependent chronic kidney disease (HDD-CKD). Anemia is principally the result of erythropoietin deficiency, inflammation, and iron deficiency. High molecular weight iron oxide nanoparticles (IONP) are routinely… read more here.
Keywords: pyrophosphate citrate; iron; safety; ferric pyrophosphate ... See more keywords